CNBX Pharmaceuticals Inc. SEC filings CNBX
CNBX Pharmaceuticals Inc. has 301 filings in SEC EDGAR's recent list, going back to Jan 9, 2006. Its latest annual report, Form 10-K, was filed on Dec 1, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jun 24, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (auditor change). The company's fiscal year ends on August 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14C | Information statement | Feb 15, 2022 | Feb 14, 2022 |
| PRE 14C | Preliminary information statement | Feb 4, 2022 | Feb 28, 2022 |
| DEF 14C | Information statement | Aug 11, 2010 | Jul 30, 2010 |
| PRE 14C | Preliminary information statement | Jul 30, 2010 | Jul 30, 2010 |
Showing 4 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CNBX (OTC)
- Fiscal year ends
- August 31
- Incorporated in
- NV
- Headquarters
- Bethesda, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1343009
- Former names
- Cannabics Pharmaceuticals Inc. (until Mar 16, 2022); American Mining Corp (until May 1, 2014); Thrust Energy Corp. (until May 10, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.